University of Chicago Medicine is an Comprehensive Cancer Center located in Chicago, IL. Dr. Hedy Kindler directs the mesothelioma program and has led numerous pivotal clinical trials that have changed mesothelioma treatment standards.
Last verified: 2026-03-09The University of Chicago mesothelioma program is recognized internationally for its clinical trial leadership. Dr. Hedy Kindler has been principal investigator on multiple landmark mesothelioma studies and serves as a key opinion leader in the field. The program treats both pleural and peritoneal mesothelioma with a multidisciplinary approach combining surgery, chemotherapy, immunotherapy, and investigational therapies.
The program offers comprehensive surgical options including pleurectomy with decortication, extrapleural pneumonectomy, and cytoreductive surgery with HIPEC. As a leader in mesothelioma clinical trials, the center often has access to novel therapies before they are widely available. The medical oncology team has expertise in immunotherapy combinations, targeted therapy, and mesothelioma-specific chemotherapy regimens.
Our team can help connect you with mesothelioma specialists at University of Chicago Medicine and explain your treatment options and legal rights.
Call 773-702-1000 for appointments. The cancer center provides patient navigation, social work, financial counseling, and nutrition services. Lodging assistance is available through local partnerships.
Phone: 773-702-1000
Website: uchicagomedicine.org/cancer
Address: 5841 S Maryland Ave, Chicago, IL 60637
Yes. The University of Chicago is a national leader in mesothelioma clinical trials and research, led by Dr. Hedy Kindler, one of the world's foremost mesothelioma medical oncologists.
Yes. The University of Chicago frequently has 5-10 active mesothelioma clinical trials, including studies of immunotherapy, targeted therapy, and novel treatment combinations. Dr. Kindler has been PI on multiple pivotal trials.
University of Chicago Medicine in Chicago, IL is an NCI-designated Comprehensive Cancer Center offering mesothelioma treatment including surgery, chemotherapy, immunotherapy, and clinical trials. Contact the center directly to schedule a consultation or request a second opinion.
University of Chicago Medicine in Chicago is widely recognized as a leading mesothelioma treatment center in Illinois. As an NCI-designated Comprehensive Cancer Center, it offers specialized surgery, chemotherapy, immunotherapy, and clinical trials for mesothelioma patients.
If you or a loved one has been treated at University of Chicago Medicine for mesothelioma, our legal team can help you pursue the compensation you deserve while you focus on treatment. Contact us for a free, confidential consultation.
Or call us 24/7: 1-800-400-1805
Information last verified: 2026-03-09
Sources:
